OTCPicks.com’s Daily Small Cap and Microcap Newsletter presents a range of the hottest small cap stocks on trading on the OTC and OTCBB markets. In addition to our Newsletters, OTCPicks.com is quickly becoming the premier community destination for small cap and microcap traders to meet up and discuss their top stock picks. Visit http://www.otcpicks.com/ today to join this growing community.
Our Stocks to Watch today include myPhotopipe.com Inc. (OTC: MPPC), Point Blank Solutions Inc. (OTC: PBSO), Enzyme Environmental Solutions Inc. (OTC: EESO), Repligen Corporation (NASDAQ: RGEN), Immunicon Corporation (NASDAQ: IMMC)
For the complete newsletter please visit: http://www.otcpicks.com/daily-market-movers/index.php
For more in-depth coverage of small cap stocks visit http://www.otcpicks.com/
MYPHOTOPIPE.COM INCORPORATED (OTC: MPPC)
"Up 16.67% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/MPPC.php
Company Profile: http://www.otcpicks.com/myphotopipe/myphotopipe-2.htm
MyPhotopipe.com Inc. is a US-based provider of online digital photo processing and related services catering to high-end amateur and professional photographers. The Company’s primary web portal is http://www.myphotopipe.com/. Its services include photo finishing and printing, online sharing, photo books, digital photo templates, and online hosting and selling of photographs. The Company provides services to more than 18,500 professional and high-end amateur photographers nationwide; more than 190,000 copies of its software have been downloaded and are in use.
POINT BLANK SOLUTIONS (OTC: PBSO)
"Up 15.79% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/PBSO.php
Point Blank Solutions, Inc. engages in the manufacture and provision of bullet, fragmentation, and stab resistant apparel and related ballistic accessories. It offers bullet- and projectile-resistant garments, fragmentation protective vests, slash, and stab protective armor. The company also manufactures and distributes sports medicine; and health support and other products, including knee, ankle, elbow, wrist and back supports, and braces that assist athletes, weekend sports enthusiasts, and general consumers in their respective sports and everyday activities. Point Blank Solutions sells its health support products under the FLEX-AIDTM brand name. Its products are sold through contracts, corporate sales force, sales agents, and a network of distributors to military, law enforcement, security and corrections personnel, and government agencies. The company was founded in 1992. It was formerly known as DHB Industries, Inc. and changed its name to Point Blank Solutions, Inc. in 2007. Point Blank Solutions is headquartered in Pompano Beach, Florida.
ENZYME ENVIRONMENTAL (OTC: EESO)
"Up 11.54% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/EESO.php
Enzyme Consultants Organization (ECO) is a U.S. based manufacturer of industrial and agricultural enzyme products. All manufacturing, testing, and formulating are conducted in its manufacturing plant, located in Fort Wayne, Indiana. ECO strives to become a leader in ecological friendly or “Green Products” targeting the industrial and agricultural markets. It is our goal to have the best performing products on the market in each industry. Developing a growing and satisfied customer base is our number one marketing strategy.
REPLIGEN CORPORATION (NASD: RGEN)
"Up 14.43% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/RGEN.php
Repligen Corporation, a biopharmaceutical company, engages in the research and development of therapeutics for the treatment of central nervous system diseases. It manufactures and markets Protein A product, which is used in the production of various therapeutic monoclonal antibodies. The company also markets SecreFlo, a synthetic form of the hormone secretin, which is used as an aid in the diagnosis of certain diseases of the pancreas. Repligen sells Protein A products to chromatography companies, diagnostics companies, biopharmaceutical companies, and laboratory researchers primarily through value-added resellers and distributors in the United States and internationally; and markets SecreFlo directly to gastroenterologists in the United States. The company also conducts drug development programs for diseases, such as bipolar disorder and neurodegeneration. Its development stage products include RG1068, a Phase II clinical trial product that improve the detection of structural abnormalities of the pancreatic ducts during MRI imaging of the pancreas; and RG2417, a Phase II clinical trial product, is a biological compound used for the synthesis of DNA and RNA in patients with bipolar depression. Repligen has a research and development agreement with the Stanley Medical Research Institute for the development of RG2417. The company was founded in 1981 and is headquartered in Waltham, Massachusetts.
IMMUNICON CORPORATION (NASD: IMMC)
"Up 7.41% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/IMMC.php
Immunicon Corporation and its subsidiaries engage in the development, manufacture, marketing, and sale of proprietary cell-based diagnostic and research products, and services with a focus on cancer. It develops technologies that identify, count, and characterize a small number of circulating tumor cells (CTC) and other rare cells present in a blood sample of a patient. The company offers CellSave Preservative tube, an evacuated blood collection tube with preservative; CellTracks AutoPrep system, an automated instrument to capture and label cells from 7.5 ml blood samples; CellTracks MagNest Cell Presentation device, a device that presents magnetically labeled cells for analysis; CellTracks Analyzer, a semi-automated fluorescence microscope used to count and characterize cells; and CellSearch Circulating Tumor Cell kit that is used for counting CTCs. It also offers CellSearch Profile kit, which is used to isolate CTCs for subsequent molecular or cellular analysis; CellTracks Endothelial Cell kit that is used in isolating and counting endothelial cells; CellTracks Bone Marrow Tumor kit, which is used to count tumor cells in a bone marrow sample; Tumor Profiling Reagents for CTC characterization; and CellTracks CEC Profile kit that is used to isolate CECs for molecular or cell analysis. The company sells its products to hospitals, reference laboratories, oncology practices, cancer treatment centers, clinical research organizations, and pharmaceutical/biotechnology companies in the United States, Europe, Japan, and Hong Kong. Immunicon has collaboration agreements with Veridex, LLC; Diagnostic HYBRIDS, Inc.; KREATECH Biotechnology B.V.; and University of Twente and STW. The company was founded in 1983 and is based in Huntingdon Valley, Pennsylvania.
About OTCPicks.com
OTCPicks.com is fast becoming the premier Internet destination for investors seeking information on smallcap and microcap companies. The web site features companies in Profile Campaigns, Executive Interviews and Research Reports authored by our financial writers. We publish our Daily Market Movers Digest Newsletter to opt-in investor members. OTCPicks.com presents the latest information for the discerning small cap and microcap investor. The site features informative articles on microcap investing, the top penny stock picks, and a wealth of small cap research on vertical markets. To feature a company on OTCPicks.com, please contact our publisher, Brian Dean at 972-546-3740, or via email at publisher@otcpicks.com.
Forward-Looking Statement: This press release includes "forward-looking statements" within the meaning of the federal securities laws, commonly identified by such terms as "believes," "looking ahead," "anticipates," "estimates" and other terms with similar meaning. Although the Company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Important factors that could cause actual results to differ materially from the Company's projections and expectations are disclosed in the Company's filings with the Securities and Exchange Commission. All forward-looking statements in this press release are expressly qualified by such cautionary statements and by reference to the underlying assumptions.
Disclosure: OTCPicks.com has been compensated four hundred thousand free trading shares from a non-controlling third party for MPPC advertising and promotional services.
OTCPicks.com is not a registered investment advisers or broker/dealer. OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk.
